期刊文献+

淋巴化疗及其在消化道恶性肿瘤中的应用 被引量:1

下载PDF
导出
摘要 转移是恶性肿瘤的基本生物学特征,也是导致术后肿瘤复发和患者死亡的主要因素。淋巴转移是恶性肿瘤最常见的转移途径,淋巴化疗是恶性肿瘤辅助化疗的合理途径之一,较常规的全身化疗更明显地提高肿瘤周围淋巴组织的化疗药物浓度,可减少全身化疗副作用,提高化疗效果。
出处 《中国现代普通外科进展》 CAS 2008年第5期422-424,共3页 Chinese Journal of Current Advances in General Surgery
  • 相关文献

参考文献15

  • 1孟强,李会晨,崔龙,孟荣贵.消化道恶性肿瘤淋巴化疗的现状[J].中国实用外科杂志,2006,26(2):145-147. 被引量:11
  • 2李义生,张泰臻,王书奎,林惠华,陈志坦,袁爱华.进展期胃癌围手术期的淋巴免疫化疗[J].临床外科杂志,2001,9(5):285-287. 被引量:4
  • 3Ito T, Hagiwara A, Takagi T, et al. Local administration of methotrexate bound to activated carbon particles (MTX-CH) for treating cancers in mice[J]. Anticancer Res, 2003,23(2B):1401-1404.
  • 4Fujiyama J, Nakase Y, Mochizuki S, et al. Fundamental studies on locally injected methotrexate bound to activated carbon particles (MTX-CH) [J]. Gan To Kagaku Ryoho, 2004,31(11):1844-1846.
  • 5Nakase Y, Hagiwara A, Kin S, et al. Intratumoral administration of methotrexate bound to activated carbon particles: antitumor effectiveness against human colon carcinoma xenografts and acute toxicity in mice[J]. J Pharmacol Exp Ther , 2004,311(1):382-387.
  • 6Jansen M, Jansen PL, Fass J, et al. Influence of intraperitoneal therapy with mitomycin C adsorbed on activated carbon on anastomotie and wound healing in rats [J]. Dig Dis Sci, 2002,47(9):1992-1997.
  • 7严忠勤,钟裕国,温玉明,邱成平.趋淋巴抗癌药丝裂霉素-右旋糖酐偶联物的合成及生物学性质的研究[J].中国药物化学杂志,1999,9(4):240-244. 被引量:9
  • 8Akamo Y, Mizuno I, Yotsuyanagi T, et al. Chemotherapy targeting regional lymph nodes by gastric subrnucosal injection of liposomal adriamycin in patients with gastric carcinoma [J].Jan J Cancer Res, 1994,85(6):652-658.
  • 9Ohgaki M, Takenaka A, Shiomi A, et al. Intraperitoneal chemotherapy against peritoneal carcinomatosis of gastric cancer with activated carbon particles adsorbing mitomycin C for four patients[J]. Gan To Kagaku Ryoho, 2004,31(11):1858-1860.
  • 10周锡庚 王一春 郁宝铭 等.直肠癌术前5-FU辅助化疗给药途径和剂型的研究.中华肿瘤杂志,1988,10(2):81-84.

二级参考文献20

  • 1余成仿,王吉甫.大肠癌术后复发和转移的临床研究─—附82例分析[J].中国普通外科杂志,1994,3(2):79-82. 被引量:4
  • 2冯碧波,郎景和,李大魁.阿霉素脂质体淋巴管灌注的靶向效果[J].中华妇产科杂志,1997,32(3):156-158. 被引量:2
  • 3周锡庚 王一春 等.直肠癌术前5-Fu辅助化疗给药途径和剂型的研究[J].中华肿瘤杂志,1988,10:81-83.
  • 4郑家伟 陈宝勇.-[J].国外医学肿瘤分册,1995,22(6):343-345.
  • 5Ohgaki M,Takenaka A,Shiomi A,et al.Intraperitoneal chemotherapy against peritoneal carcinomatosis of gastric cancer with activated carbon particles adsorbing mitomycin C for four patients[J].Gan To Kagaku Ryoho,2004,31(11):1858-1860.
  • 6Ito T,Hagiwara A,Takagi T,et al.Local ainistration of methotrexate bound to activated carbon particles (MTX-CH) for treating cancers in mice[J].Anticancer Res,2003,23 (2B):1401-1404.
  • 7Fujiyama J,Nakase Y,Mochizuki S,et al.Fundamental studies on locally injected methotrexate bound to activated carbon particles (MTX-CH)[J].Gan To Kagaku Ryoho,2004,31(11):1844-1846.
  • 8Nakase Y,Hagiwara A,Kin S,et al.Intratumoral ainistration of methotrexate bound to activated carbon particles:antitumor effectiveness against human colon carcinoma xenografts and acute toxicity in mice[J].J Pharmacol Exp Ther,2004,311(1):382-387.
  • 9Jansen M,Jansen PL,Fass J,et a1.Influence of intraperitoneal therapy with mitomycin C adsorbed on activated carbon on anastomotic and wound healing in rats[J].Dig Dis Sci,2002,47(9):1992-1997.
  • 10Nishioka Y,Yoshino H.Lymphatic targeting with nanoparticulate system[J].Adv Drug Deliv Rev,2001,47(1):55-64.

共引文献28

同被引文献25

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部